What it is
A clinical trial is a research study that tests whether a medical product or approach is safe and whether it works. Stem cell therapy trials study cells, often called mesenchymal stem/stromal cells (MSCs) or blood-forming cells, for various conditions. Being in a trial is different from receiving an approved treatment.
In the U.S., the only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders, used in specialist transplant settings. Most other clinic offerings, including MSC, adipose/SVF, umbilical cord, Wharton's jelly and perinatal products, are not FDA-approved. No exosome product is FDA-approved, and the FDA has warned the public about unapproved stem cell and exosome products.
Legitimate trials are typically registered on ClinicalTrials.gov, reviewed by an Institutional Review Board (IRB), and run under a defined plan. Evidence for many uses of stem cells is still limited or investigational, which is exactly why careful research matters. Calling something 'holistic' or 'alternative' does not change its FDA status.
How it’s traditionally been approached
Research on stem cells has traditionally taken place at academic medical centers, hospitals and dedicated research sites. Hematology and transplant centers have long experience with blood-forming cell transplants for certain blood and immune disorders. Other studies, including MSC research, are generally run by clinical research sites under formal oversight.
People have usually found trials by searching ClinicalTrials.gov, asking their own physician or specialist, or contacting a university medical center. Study listings describe who may take part, what is being tested, where it is located, and who is responsible for the study.
Trials usually involve an eligibility screening, an informed consent process, and scheduled follow-up. Researchers generally do not guarantee benefit, and participants may sometimes receive a placebo or a comparison approach, depending on how the study is designed.
How the right provider may help
A licensed provider, such as a physician at a hematology and transplant center or a research site, may help you understand whether a particular trial is real, what it is testing, and whether it could be appropriate for your situation. A first visit is usually a conversation and an evaluation, not a commitment to join anything. Only a licensed clinician can decide what is appropriate for you after an evaluation.
Useful questions to ask include: Is this study registered on ClinicalTrials.gov, and what is its listing number? Which IRB oversees it? What is the regulatory status of the product being studied? What are the known and possible risks, and what alternatives exist? Will I receive written informed consent that covers all of this, and can I leave the study at any time?
You can also verify the clinician's license with your state medical board and ask whether your own doctor can review the study details with you. A trustworthy team should welcome these questions and answer them clearly without pressure.
The whole-person view
Health decisions involve the whole person. Body, mind and stress affect each other, and a long search for answers can bring hope, worry and fatigue all at once. Giving yourself time, and talking things through with people you trust, can make complex choices feel more manageable.
Some people find that body-based support, such as the approaches offered through Somatic Experiences, helps them feel more settled while they weigh decisions. Others value talk therapy, such as that available through Therapists.plus, for working through uncertainty or stress. These are supportive options that sit alongside, not in place of, care from licensed medical professionals.
Somatic Experiences: embodiment and movement →Somatic Experiences: nervous system regulation →Therapists.plus: mind body connection →
Keep in mind
- Licensed professionals should guide your care; this page is educational only and is not medical advice.
- Red flags include cure-all or 'treats everything' claims, being asked to pay to join a 'clinical trial', testimonials offered in place of evidence, and pressure to travel abroad or across states for treatment.
- Always verify a product's FDA status, confirm the study is on ClinicalTrials.gov with IRB oversight, check the clinician's license with the state medical board, and get written informed consent covering risks and alternatives.
- For emergencies call 911; in a crisis call or text 988 (Suicide & Crisis Lifeline).
For your safety, sensitive situations are best guided by licensed professionals.
Providers who often help
Get matched privatelyFrequently asked questions
How do I find a legitimate stem cell therapy clinical trial?
Start by searching ClinicalTrials.gov, the U.S. registry of studies, and ask your own doctor or a specialist to help you review options. University medical centers, hematology and transplant centers, and MSC clinical research sites may also run registered studies. Always confirm the listing details before contacting a site.
How can I verify that a stem cell clinical trial is real?
Check that the study has a ClinicalTrials.gov listing, that an IRB oversees it, and that the sponsor and location match what the clinic tells you. Confirm the clinician's license with your state medical board, and ask about the product's FDA status. A real study should provide written informed consent covering risks and alternatives.
Is it normal to pay to join a stem cell clinical trial?
Being asked to pay to join a 'clinical trial' is a recognized red flag. Legitimate research is generally structured and funded differently from a clinic selling a service, though a research team can explain exactly what costs, if any, apply to you. If you are unsure, ask your own doctor to review the offer before you agree to anything.
Are stem cell therapy treatments FDA-approved?
In the U.S., the only FDA-approved stem-cell products are cord-blood-derived hematopoietic progenitor cell (HPC) products for certain blood and immune disorders, used in specialist transplant settings. Most clinic offerings, including MSC, adipose/SVF, umbilical cord, Wharton's jelly and perinatal products, are not FDA-approved. The FDA has also warned the public about unapproved stem cell products.
Are exosome treatments FDA-approved?
No, no exosome product is FDA-approved. The FDA has warned the public about unapproved exosome products marketed by some clinics. Ask a licensed clinician about the regulatory status of anything you are offered.
What should I ask before joining a stem cell clinical trial?
Ask for the ClinicalTrials.gov number, the name of the overseeing IRB, the product's FDA status, and the known and possible risks and alternatives. Request written informed consent and time to review it with your own doctor. You should also be told that you may leave a study at any time.
Educational resource. StemCell.biz shares general information and connects people with independent providers. It is not medical advice, diagnosis or treatment. Talk with a licensed professional about your health.